Lido Advisors
LMAT icon

Lido Advisors’s LeMaitre Vascular LMAT Stock Holding History

Lido Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,376
Closed -$335K – 1001
2022
Q2 		$335K Buy
+7,376
New +$330K ﹤0.01% 688

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Lido Advisors's LMAT Position: Q3 2022 in Review

Lido Advisors sold out of LeMaitre Vascular (LMAT) in Q3 2022, closing a stake of 7,376 shares — an estimated $335K sold.

Lido Advisors first reported a position in LMAT in Q2 2022 and held it in 1 quarter. The position peaked at $335K in Q2 2022. 189 funds tracked by Wall St. Rank hold LMAT as of Q3 2022.

  • Lido Advisors reported no remaining LeMaitre Vascular position as of Q3 2022 after selling out during the quarter.
  • Lido Advisors sold 7,376 LeMaitre Vascular shares in Q3 2022, an estimated $335K.
  • Lido Advisors first reported a position in LeMaitre Vascular in Q2 2022 and held it in 1 quarter.
  • Lido Advisors's LeMaitre Vascular position peaked at $335K in Q2 2022.
  • 189 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2022.

Based on Lido Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.